Physician profile
Megan R Davis
NPI 1255623609
$11,248.81
in general payments reported to CMS, 2019-2025
50 companies · $8,580 in 2025
The $8,580 reported for 2025 was more than what 99% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $637 · 2021: $282 · 2022: $323 · 2023: $236 · 2024: $367 · 2025: $8,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,287 · Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,287.25 |
| Food and Beverage | $895.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $8,478.21 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $345.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $240.84 | 2019-2025 | |
| Eisai INC. | $215.71 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $198.69 | 2019-2025 | Fruzaqla, Ninlaro |
| Regeneron Healthcare Solutions, INC. | $139.81 | 2019-2023 | Libtayo |
| Genzyme Corporation | $129.50 | 2019-2023 | |
| Amgen INC. | $120.40 | 2019-2022 | |
| Daiichi Sankyo INC. | $94.98 | 2019-2025 | Enhertu |
| Astrazeneca Pharmaceuticals Lp | $92.06 | 2019-2025 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $82.24 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $82.09 | 2019-2025 | |
| Incyte Corporation | $75.27 | 2019-2024 | Monjuvi, Pemazyre, Jakafi |
| Exelixis INC. | $73.55 | 2019-2025 | Cabometyx |
| Taiho Oncology, INC. | $66.90 | 2019-2023 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.